These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

196 related articles for article (PubMed ID: 14980073)

  • 21. Protective roles of mast cells against enterobacterial infection are mediated by Toll-like receptor 4.
    Supajatura V; Ushio H; Nakao A; Okumura K; Ra C; Ogawa H
    J Immunol; 2001 Aug; 167(4):2250-6. PubMed ID: 11490012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Selective priming to Toll-like receptor 4 (TLR4), not TLR2, ligands by P. acnes involves up-regulation of MD-2 in mice.
    Romics L; Dolganiuc A; Kodys K; Drechsler Y; Oak S; Velayudham A; Mandrekar P; Szabo G
    Hepatology; 2004 Sep; 40(3):555-64. PubMed ID: 15349893
    [TBL] [Abstract][Full Text] [Related]  

  • 23. In vitro activation of murine peritoneal macrophages by ultraviolet B radiation: upregulation of CD18, production of NO, proinflammatory cytokines and a signal transduction pathway.
    Sethi G; Sodhi A
    Mol Immunol; 2004 Apr; 40(18):1315-23. PubMed ID: 15072850
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chitin particle-induced cell-mediated immunity is inhibited by soluble mannan: mannose receptor-mediated phagocytosis initiates IL-12 production.
    Shibata Y; Metzger WJ; Myrvik QN
    J Immunol; 1997 Sep; 159(5):2462-7. PubMed ID: 9278339
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Toll-like receptor 2 mediates inflammatory cytokine induction but not sensitization for liver injury by Propioni- bacterium acnes.
    Romics L; Dolganiuc A; Velayudham A; Kodys K; Mandrekar P; Golenbock D; Kurt-Jones E; Szabo G
    J Leukoc Biol; 2005 Dec; 78(6):1255-64. PubMed ID: 16204620
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TLR4, but not TLR2, mediates IFN-beta-induced STAT1alpha/beta-dependent gene expression in macrophages.
    Toshchakov V; Jones BW; Perera PY; Thomas K; Cody MJ; Zhang S; Williams BR; Major J; Hamilton TA; Fenton MJ; Vogel SN
    Nat Immunol; 2002 Apr; 3(4):392-8. PubMed ID: 11896392
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Toll-like receptor 4-deficient mice have reduced bone destruction following mixed anaerobic infection.
    Hou L; Sasaki H; Stashenko P
    Infect Immun; 2000 Aug; 68(8):4681-7. PubMed ID: 10899873
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Inhibition of inducible nitric-oxide synthase expression by (5R)-5-hydroxytriptolide in interferon-gamma- and bacterial lipopolysaccharide-stimulated macrophages.
    Zhou R; Zheng SX; Tang W; He PL; Li XY; Yang YF; Li YC; Geng JG; Zuo JP
    J Pharmacol Exp Ther; 2006 Jan; 316(1):121-8. PubMed ID: 16166270
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Different Toll-like receptor agonists induce distinct macrophage responses.
    Jones BW; Means TK; Heldwein KA; Keen MA; Hill PJ; Belisle JT; Fenton MJ
    J Leukoc Biol; 2001 Jun; 69(6):1036-44. PubMed ID: 11404392
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Spirulina lipopolysaccharides inhibit tumor growth in a Toll-like receptor 4-dependent manner by altering the cytokine milieu from interleukin-17/interleukin-23 to interferon-γ.
    Okuyama H; Tominaga A; Fukuoka S; Taguchi T; Kusumoto Y; Ono S
    Oncol Rep; 2017 Feb; 37(2):684-694. PubMed ID: 28075473
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Induction of macrophage nitric oxide production by Gram-negative flagellin involves signaling via heteromeric Toll-like receptor 5/Toll-like receptor 4 complexes.
    Mizel SB; Honko AN; Moors MA; Smith PS; West AP
    J Immunol; 2003 Jun; 170(12):6217-23. PubMed ID: 12794153
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neuroprotective effects of cyclooxygenase-2 inhibitor celecoxib against toxicity of LPS-stimulated macrophages toward motor neurons.
    Huang Y; Liu J; Wang LZ; Zhang WY; Zhu XZ
    Acta Pharmacol Sin; 2005 Aug; 26(8):952-8. PubMed ID: 16038627
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Toll-like receptor signaling in anti-cancer immunity.
    Okamoto M; Sato M
    J Med Invest; 2003 Feb; 50(1-2):9-24. PubMed ID: 12630564
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The immunomodulator ginsan induces resistance to experimental sepsis by inhibiting Toll-like receptor-mediated inflammatory signals.
    Ahn JY; Choi IS; Shim JY; Yun EK; Yun YS; Jeong G; Song JY
    Eur J Immunol; 2006 Jan; 36(1):37-45. PubMed ID: 16342327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Neisseria meningitidis can induce pro-inflammatory cytokine production via pathways independent from CD14 and toll-like receptor 4.
    Sprong T; van der Ley P; Steeghs L; Taw WJ; Verver-Janssen TJ; Netea MG; van der Meer JW; van Deuren M
    Eur Cytokine Netw; 2002; 13(4):411-7. PubMed ID: 12517725
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Inhibition of lipopolysaccharide-inducible nitric oxide synthase and IL-1beta through suppression of NF-kappaB activation by 3-(1'-1'-dimethyl-allyl)-6-hydroxy-7-methoxy-coumarin isolated from Ruta graveolens L.
    Raghav SK; Gupta B; Shrivastava A; Das HR
    Eur J Pharmacol; 2007 Mar; 560(1):69-80. PubMed ID: 17292351
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Panax ginseng aqueous extract prevents pneumococcal sepsis in vivo by potentiating cell survival and diminishing inflammation.
    Nguyen CT; Luong TT; Lee SY; Kim GL; Kwon H; Lee HG; Park CK; Rhee DK
    Phytomedicine; 2015 Oct; 22(11):1055-61. PubMed ID: 26407948
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Quantitative aspects of lipopolysaccharide and cytokine requirements to generate nitric oxide in macrophages from LPS-hyporesponsive (Lps(d)) C3H/HeJ mice.
    Kmonícková E; Zídek Z
    Folia Microbiol (Praha); 2004; 49(6):737-44. PubMed ID: 15881412
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bacterial lipopolysaccharide induces transforming growth factor beta and hepatocyte growth factor through toll-like receptor 2 in cultured human colon cancer cells.
    Yoshioka T; Morimoto Y; Iwagaki H; Itoh H; Saito S; Kobayashi N; Yagi T; Tanaka N
    J Int Med Res; 2001; 29(5):409-20. PubMed ID: 11725828
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Activity of gelatins to induce secretion of a variety of cytokines from murine peritoneal exudate macrophages.
    Kojima T; Inamura Y; Koide T; Nagata H; Paeng N; Sasanabe R
    Cancer Biother Radiopharm; 2005 Aug; 20(4):417-25. PubMed ID: 16114990
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.